Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical characteristics and thromboembolic risk of atrial fibrillation patients with and without congestive heart failure. Results from the CRATF study.
Balsam P, Gawałko M, Peller M, Tymińska A, Ozierański K, Zaleska M, Żukowska K, Szepietowska K, Maciejewski K, Grabowski M, Borkowski M, Kołtowski Ł, Praska-Oginska A, Zaboyska I, Opolski G, Bednarski J. Balsam P, et al. Among authors: bednarski j. Medicine (Baltimore). 2018 Nov;97(45):e13074. doi: 10.1097/MD.0000000000013074. Medicine (Baltimore). 2018. PMID: 30407304 Free PMC article.
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo.
Bentley-Lewis R, Aguilar D, Riddle MC, Claggett B, Diaz R, Dickstein K, Gerstein HC, Johnston P, Køber LV, Lawson F, Lewis EF, Maggioni AP, McMurray JJ, Ping L, Probstfield JL, Solomon SD, Tardif JC, Wu Y, Pfeffer MA; ELIXA Investigators. Bentley-Lewis R, et al. Am Heart J. 2015 May;169(5):631-638.e7. doi: 10.1016/j.ahj.2015.02.002. Epub 2015 Feb 12. Am Heart J. 2015. PMID: 25965710 Free article. Clinical Trial.
Comparison of clinical characteristics of real-life atrial fibrillation patients treated with vitamin K antagonists, dabigatran, and rivaroxaban: results from the CRAFT study.
Balsam P, Ozierański K, Tymińska A, Żukowska K, Zaleska M, Szepietowska K, Maciejewski K, Peller M, Grabowski M, Lodziński P, Praska-Ogińska A, Zaboyska I, Kołtowski Ł, Kowalczuk A, Bednarski J, Filipiak KJ, Opolski G. Balsam P, et al. Among authors: bednarski j. Kardiol Pol. 2018;76(5):889-898. doi: 10.5603/KP.a2018.0027. Epub 2018 Jan 19. Kardiol Pol. 2018. PMID: 29350386 Free article. Clinical Trial.
District versus academic hospitals: differences in the clinical characteristics of patients with atrial fibrillation without valvular heart disease treated with oral anticoagulants.
Bednarski J, Balsam P, Tymińska A, Ozierański K, Żukowska K, Zaleska M, Szepietowska K, Maciejewski K, Peller M, Praska-Oginska A, Zaboyska I, Opolski G. Bednarski J, et al. Pol Arch Intern Med. 2018 Mar 17;128(5):274-279. doi: 10.20452/pamw.4320. Epub 2018 Mar 17. Pol Arch Intern Med. 2018. PMID: 29549695 Free article.
Randomized controlled clinical trials versus real-life atrial fibrillation patients treated with oral anticoagulants. Do we treat the same patients?
Balsam P, Tymińska A, Ozierański K, Zaleska M, Żukowska K, Szepietowska K, Maciejewski K, Peller M, Grabowski M, Lodziński P, Kołtowski Ł, Praska-Ogińska A, Zaboyska I, Bednarski J, Filipiak KJ, Opolski G. Balsam P, et al. Among authors: bednarski j. Cardiol J. 2020;27(5):590-599. doi: 10.5603/CJ.a2018.0135. Epub 2018 Nov 8. Cardiol J. 2020. PMID: 30406937 Free PMC article.
Comparative effectiveness of torasemide versus furosemide in symptomatic therapy in heart failure patients: Preliminary results from the randomized TORNADO trial.
Balsam P, Ozierański K, Marchel M, Gawałko M, Niedziela Ł, Tymińska A, Sieradzki B, Sieradzki M, Fojt A, Bakuła E, Główczyńska R, Peller M, Markulis M, Bednarski J, Kowalik R, Cacko A, Niewiński G, Filipiak KJ, Opolski G, Grabowski M. Balsam P, et al. Among authors: bednarski j. Cardiol J. 2019;26(6):661-668. doi: 10.5603/CJ.a2019.0114. Epub 2020 Jan 7. Cardiol J. 2019. PMID: 31909470 Free PMC article. Clinical Trial.
Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry.
Gorczyca I, Jelonek O, Uziębło-Życzkowska B, Chrapek M, Maciorowska M, Wójcik M, Błaszczyk R, Kapłon-Cieślicka A, Gawałko M, Budnik M, Tokarek T, Rajtar-Salwa R, Bil J, Wojewódzki M, Szpotowicz A, Bednarski J, Bakuła-Ostalska E, Tomaszuk-Kazberuk A, Szyszkowska A, Wełnicki M, Mamcarz A, Wożakowska-Kapłon B. Gorczyca I, et al. Among authors: bednarski j. J Clin Med. 2020 Nov 5;9(11):3565. doi: 10.3390/jcm9113565. J Clin Med. 2020. PMID: 33167503 Free PMC article.
Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention, including compliance with current guidelines-data from the POLish Atrial Fibrillation (POL-AF) Registry.
Uziębło-Życzkowska B, Krzesiński P, Maciorowska M, Gorczyca I, Jelonek O, Wójcik M, Błaszczyk R, Kapłon-Cieślicka A, Gawałko M, Tokarek T, Rajtar-Salwa R, Bil J, Wojewódzki M, Szpotowicz A, Krzciuk M, Bednarski J, Bakuła-Ostalska E, Tomaszuk-Kazberuk A, Szyszkowska A, Wełnicki M, Mamcarz A, Wożakowska-Kapłon B. Uziębło-Życzkowska B, et al. Among authors: bednarski j. Cardiovasc Diagn Ther. 2021 Feb;11(1):14-27. doi: 10.21037/cdt-20-839. Cardiovasc Diagn Ther. 2021. PMID: 33708474 Free PMC article.
Characteristics and Treatment of Atrial Fibrillation with Respect to the Presence or Absence of Heart Failure. Insights from the Multicenter Polish Atrial Fibrillation (POL-AF) Registry.
Gawałko M, Budnik M, Gorczyca I, Jelonek O, Uziębło-Życzkowska B, Maciorowska M, Wójcik M, Błaszczyk R, Tokarek T, Rajtar-Salwa R, Bil J, Wojewódzki M, Szpotowicz A, Krzciuk M, Bednarski J, Bakuła-Ostalska E, Tomaszuk-Kazberuk A, Szyszkowska A, Wełnicki M, Mamcarz A, Kapłon-Cieślicka A. Gawałko M, et al. Among authors: bednarski j. J Clin Med. 2021 Mar 24;10(7):1341. doi: 10.3390/jcm10071341. J Clin Med. 2021. PMID: 33804992 Free PMC article.
104 results